Ensign Group (ENSG) Stock Forecast & Price Target

Ensign Group is supported by a resilient operating model that combines higher-acuity post-acute care, improving skilled mix, and rising occupancy, with same-facility occupancy at 84.1% and transitioning occupancy at 86.1% in 3Q26, alongside strong Medicare and managed care day growth. Its outlook is further strengthened by disciplined M&A and turnaround execution, including 22 added operations during and since the quarter and 122 additions since 2024, while a deep leadership bench and a strong balance sheet with $337.6 million in cash and $731.6 million of revolver capacity support continued expansion. The company also appears well positioned in Florida, where seasoned local leadership, a stable rate environment, and favorable demographics could unlock long-term upside, helping justify higher 2026 adjusted EPS guidance of $7.94 to $8.02 and the view that Ensign can sustain above-peer growth.

Ensign Group is vulnerable to a downside case in which FY27E adjusted EBITDAR falls 10% below estimate, reflecting integration headwinds that could compress valuation toward 10.0x 2027E EBITDAR, near recent trough levels. Its heavy dependence on Medicare and Medicaid reimbursement leaves earnings exposed to adverse regulatory changes, while nursing labor shortages can lift costs, pressure occupancy, and weaken profitability. Competitive pressure, growing Medicare Advantage penetration, acquisition integration risk, and possible disruptions to capital access add further downside to the largely skilled-services-driven revenue base.